Publication | Open Access

Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

InflammationCytokineHematological MalignancyImmune Cell DevelopmentImmunologyTumor ImmunityHematologyPathologyImmune SurveillanceImmune RegulationMyeloma Proliferative ComponentImmune FunctionIndolent Multiple MyelomaImmune SystemMedicineChronic Disease State